FibroBiologics (STU:SG0) Short-Term Capital Lease Obligation : €0.34 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Short-Term Capital Lease Obligation?

FibroBiologics's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0.34 Mil.

FibroBiologics's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (€0.33 Mil) to Dec. 2023 (€0.33 Mil) and increased from Dec. 2023 (€0.33 Mil) to Mar. 2024 (€0.34 Mil).

FibroBiologics's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.31 Mil) and increased from Dec. 2022 (€0.31 Mil) to Dec. 2023 (€0.33 Mil).

FibroBiologics Short-Term Capital Lease Obligation Historical Data

The historical data trend for FibroBiologics's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Short-Term Capital Lease Obligation Chart

FibroBiologics Annual Data

Trend

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

0.31

0.33

FibroBiologics Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial				-	0.32	0.33	0.33	0.34

FibroBiologics Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

FibroBiologics Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

FibroBiologics (STU:SG0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (STU:SG0) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

FBLG:USA

Address

455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598

Website

https://www.fibrobiologics.com

FibroBiologics Inc is an early-stage, cell therapy company. Its primary focus is the initiation and progression of preclinical studies and clinical-stage FDA trials related to fibroblast treatments for Degenerative Disc Disease, Multiple Sclerosis, Cancer, Wound Healing, and other diseases.

FibroBiologics (STU:SG0) Headlines

No Headlines